Meta-analysis of the dose-response relationship of SSRI in obsessive–compulsive disorder

Bloch, M H, McGuire, J, Landeros-Weisenberger, A, Leckman, J F, Pittenger, C·2010·Molecular Psychiatry
DOI 10.1038/mp.2009.50

Cited by (318)

Items 301–318 of 318

  1. Serotonin Synthesis Amplification to Augment the Therapeutic Efficacy of Serotonin Reuptake Inhibitor Antidepressants: Five Decades of Clinical Evidence.
    Stefania Chaikali, J. Jacobsen · 2026 · Journal of Clinical Psychopharmacology
  2. Stimulation électrique par courant continu (tDCS) dans les Troubles Obsessionnels et Compulsifs résistants : effets cliniques et électrophysiologiques
    Rémy Bation · 2018
  3. Trouble obsessionnel compulsif résistant : Influence des facteurs cliniques et génétiques dans la réponse thérapeutique et prise en charge par les techniques de neurostimulation non invasives
    Ghina Harika‐Germaneau · 2020 · theses.fr (ABES)
  4. Linking macro-scale structural–functional networks to micro-scale neurotransmitter architectures in first-episode, drug-naïve OCD
    Zihan Li, Xiaopan Zhang, Jin Sun, Yuzhen Ding, Yufei Shen, Ya Tian, Yifei Zhang, Huirong Guo, Yarui Wei, Shaoqiang Han et al. · 2026 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
  5. Chapter 2. Antidepressants
    Calley H. Johnston, Muniza Anum Majoka, Matthew Macaluso, Samuel Wilkinson · 2024 · American Psychiatric Association Publishing eBooks
  6. The relationship between serotonin transporter occupancy and extracellular serotonin concentration is hyperbolic, not linear: implications for safely tapering antidepressants
    Daniel Cohrs, Bryan Shapiro · 2026 · medRxiv
  7. Optimized Oral Glutamatergic Augmentation in Refractory Home-Dominant Contamination Obsessive-Compulsive Disorder With Somatic, Affective, and Motivational Features: A Case Report of Incremental Functional Gains
    Hoi Ki Cheung, Ngo Cheung · 2026 · Cureus
  8. Clinical utility of therapeutic drug monitoring of sertraline: a transdiagnostic systematic scoping review
    Covadonga Canga-Espina, José Pablo Bullard, Begoña Tapia-Alzuguren, Adam Gędek, Enrique Aubá, Felipe Ortuño, Azucena Aldaz Pastor, Patricio Molero · 2026 · Frontiers in Pharmacology
  9. Pharmacologic Treatment of Pediatric Obsessive-Compulsive Disorder: An Evidence-Based Narrative Review
    Tarik Hadžić, Aaron Lulla, Erika L. Nurmi · 2026 · Current Developmental Disorders Reports
  10. Nutraceuticals and obsessive-compulsive disorder therapy
    Amir Hossein Mohammadi, Negin Amin, Sayed Abolfazl Tavousi, Mahmood Khaksary Mahabady, Michael Aschner, Hamed Mirzaei · 2026 · Advances in neurotoxicology
  11. Structural synaptogenesis superior to functional modulation in a pruning-based recurrent network model of OCD
    Ngo Cheung · 2026 · Frontiers in Computational Neuroscience
  12. Antidépresseurs
    Bruno Aouizerate, Dominique Servant, Alexandra Bouvard, Florence Josse · 2025 · Elsevier eBooks
  13. Rapid Symptom Reduction Following Intramuscular Ketamine in Refractory Obsessive–Compulsive Disorder: A Case Report
    Maxwell Angel · 2026 · Case Reports in Psychiatry
  14. Psilocybin restores social novelty investigation in male SAPAP3 knockout mice and engages prefrontal–hippocampal circuitry
    James J Gattuso, Bilgenur Bezcioglu, Jenna Hendey, Jennyfer M. Payet, Zoe J. Phelan, Matthew W. Hale, Anthony John Hannan, Thibault Renoir · 2026 · Molecular Psychiatry
  15. Mechanisms of Selective Serotonin Reuptake Inhibitors in Treatment-Resistant Obsessive–Compulsive Disorder: Cortico-Striatal Circuitry, Glutamatergic Dysregulation, and Neuroplastic Constraints
    Abdullah Faisal Albukhari · 2026 · Molecular Neurobiology
  16. Obsessive-compulsive disorder in adulthood: Etiology, diagnosis, and treatment
    Ulrich Voderholzer, Lena Jelinek, Rebecca Schennach, Katharina Domschke, Hans Jörgen Grabe, Dominique Endres · 2026 · Deutsches Ärzteblatt international
  17. Private-Sector Sales Trends of Antidepressants and Antipsychotics in Costa Rica, 2022–2026: An Aggregate Analysis by Active Ingredient
    Esteban Zavaleta‐Monestel, Luis Guillermo Herrera-Jiménez, Sebastián Arguedas‐Chacón, José Andrés Castro-Gamboa, Kevin Cruz-Mora, Jeaustin Mora-Jiménez, Ricardo Millán-González · 2026 · Psychoactives
  18. THE ASSOCIATION OF THE 5-HTTLPR POLYMORPHISM WITH PERINATAL ONSET OBSESSIVE-COMPULSIVE DISORDER AND DISTINCT BRAIN ACTIVATION PATTERNS: A GENETIC NEUROIMAGING STUDY
    Lauren E. Mak · 2014 · MacSphere (McMaster University)